DT MedTech
Private Company
Funding information not available
Overview
DT MedTech is a private, commercial-stage medical device company headquartered in Eindhoven, Netherlands, specializing in orthopedic implants for the ankle. Its flagship products are the FDA-approved Hintermann Series H3® and the H2® Total Ankle Replacement systems, which offer a comprehensive surgical solution for primary and revision procedures using a single instrument set. The company leverages the long-standing clinical legacy and IP of Prof. Beat Hintermann, a leading orthopedic surgeon. Its business model is centered on the sale of these implant systems to surgeons and hospitals globally.
Technology Platform
Proprietary mobile-bearing and semi-constrained designs for total ankle replacement systems, based on over 20 years of clinical IP from Prof. Beat Hintermann. Features a universal instrument set for both primary (H3) and primary/revision (H2) implants.
Opportunities
Risk Factors
Competitive Landscape
DT MedTech competes in the total ankle replacement market against major orthopedic companies including Stryker (STAR, INFINITY), Exactech, and Integra LifeSciences. Its differentiation is based on the clinical legacy of the Hintermann name and its versatile two-implant system designed for use with a single surgical tray.